Consolidated Statements of Operations (USD $)
|
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Jan. 31, 2015
|
Jan. 31, 2014
|
Jan. 31, 2015
|
Jan. 31, 2014
|
|
Revenues: | ||||
Product sales | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet |
Total revenue | 0us-gaap_Revenues | 0us-gaap_Revenues | 0us-gaap_Revenues | 0us-gaap_Revenues |
Cost of revenues | 0us-gaap_CostOfRevenue | 0us-gaap_CostOfRevenue | 0us-gaap_CostOfRevenue | 0us-gaap_CostOfRevenue |
Gross margin | 0us-gaap_GrossProfit | 0us-gaap_GrossProfit | 0us-gaap_GrossProfit | 0us-gaap_GrossProfit |
Operating Expenses: | ||||
Sales and marketing | 0us-gaap_SellingAndMarketingExpense | 309,600us-gaap_SellingAndMarketingExpense | 230,500us-gaap_SellingAndMarketingExpense | 324,600us-gaap_SellingAndMarketingExpense |
Research and development costs | 273,804us-gaap_ResearchAndDevelopmentExpense | 0us-gaap_ResearchAndDevelopmentExpense | 621,567us-gaap_ResearchAndDevelopmentExpense | 0us-gaap_ResearchAndDevelopmentExpense |
Compensation expense | 204,200us-gaap_LaborAndRelatedExpense | 92,799us-gaap_LaborAndRelatedExpense | 5,298,372us-gaap_LaborAndRelatedExpense | 1,435,060us-gaap_LaborAndRelatedExpense |
Director fees | 0us-gaap_NoninterestExpenseDirectorsFees | 0us-gaap_NoninterestExpenseDirectorsFees | 0us-gaap_NoninterestExpenseDirectorsFees | 0us-gaap_NoninterestExpenseDirectorsFees |
Legal & professional fees | 236,477us-gaap_ProfessionalFees | 33,217us-gaap_ProfessionalFees | 850,571us-gaap_ProfessionalFees | 240,731us-gaap_ProfessionalFees |
General and administrative | 742,073us-gaap_GeneralAndAdministrativeExpense | 245,464us-gaap_GeneralAndAdministrativeExpense | 2,284,143us-gaap_GeneralAndAdministrativeExpense | 529,950us-gaap_GeneralAndAdministrativeExpense |
Total operating expenses | 1,456,554us-gaap_OperatingExpenses | 681,080us-gaap_OperatingExpenses | 9,285,153us-gaap_OperatingExpenses | 2,530,341us-gaap_OperatingExpenses |
Net loss from operations | (1,456,554)us-gaap_OperatingIncomeLoss | (681,080)us-gaap_OperatingIncomeLoss | (9,285,153)us-gaap_OperatingIncomeLoss | (2,530,341)us-gaap_OperatingIncomeLoss |
Other income (expenses): | ||||
Gain on forgiveness of debt | 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax | 225,921us-gaap_ExtinguishmentOfDebtGainLossNetOfTax | 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax | 1,633,380us-gaap_ExtinguishmentOfDebtGainLossNetOfTax |
Loss on conversion of preferred stock | 0pmcb_LossOnConversionOfPreferredStock | 0pmcb_LossOnConversionOfPreferredStock | 0pmcb_LossOnConversionOfPreferredStock | (5,895,000)pmcb_LossOnConversionOfPreferredStock |
Loss on settlement of debt | 0us-gaap_GainsLossesOnExtinguishmentOfDebt | 0us-gaap_GainsLossesOnExtinguishmentOfDebt | 0us-gaap_GainsLossesOnExtinguishmentOfDebt | (3,973,795)us-gaap_GainsLossesOnExtinguishmentOfDebt |
Gain on settlement of stock recoveries | 0pmcb_GainOnSettlementOfStockRecoveries | 0pmcb_GainOnSettlementOfStockRecoveries | 2,183,332pmcb_GainOnSettlementOfStockRecoveries | 0pmcb_GainOnSettlementOfStockRecoveries |
Interest income | 22us-gaap_InterestAndOtherIncome | 149us-gaap_InterestAndOtherIncome | 1,518us-gaap_InterestAndOtherIncome | 266us-gaap_InterestAndOtherIncome |
Interest expense | (1,518)us-gaap_InterestExpense | (3,762)us-gaap_InterestExpense | (6,243)us-gaap_InterestExpense | (17,719)us-gaap_InterestExpense |
Total other income (expense) | (1,496)us-gaap_OtherNonoperatingIncomeExpense | 222,308us-gaap_OtherNonoperatingIncomeExpense | 2,178,606us-gaap_OtherNonoperatingIncomeExpense | (8,252,868)us-gaap_OtherNonoperatingIncomeExpense |
Net income (loss) | $ (1,458,050)us-gaap_NetIncomeLoss | $ (458,772)us-gaap_NetIncomeLoss | $ (7,106,547)us-gaap_NetIncomeLoss | $ (10,783,209)us-gaap_NetIncomeLoss |
Net income (loss) per common share | $ 0.00us-gaap_EarningsPerShareBasic | $ 0.00us-gaap_EarningsPerShareBasic | $ (0.01)us-gaap_EarningsPerShareBasic | $ (0.02)us-gaap_EarningsPerShareBasic |
Weighted average number of shares outstanding | 696,145,901us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 599,924,609us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 702,640,051us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 554,937,091us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
X | ||||||||||
- Definition
Gain on settlement of stock recoveries No definition available.
|
X | ||||||||||
- Definition
Loss on conversion of preferred stock No definition available.
|
X | ||||||||||
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
X | ||||||||||
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|